Intended for first and second year osteopathic medical students, COMAT FBS Targeted exams assess students’ knowledge related to a particular discipline or body system. Administered exclusively by colleges of osteopathic medicine (COMs), this targeted approach enables schools to dynamically customize their portfolio of exams to best meet evolving formative assessment needs.
| Topic | % |
|---|---|
| Hematologic Systems | 15–20% |
| Heart | 20–25% |
| Vasculature | 20–25% |
| Neurohumoral Reflex Control of Arterial Blood Pressure | 15–20% |
| Integrated Thermoregulatory Control | 3–5% |
| Pharmacologic Treatment of Cardiovascular and Hematologic Disorders and Dysfunctions | 15–20% |
| Topic | % |
|---|---|
| Adrenal Cortical And Medullary Hormones | 10–15% |
| Hypothalamic-Pituitary Axis | 10–15% |
| Parathyroid Gland | 5–10% |
| Thyroid Gland | 10–15% |
| Endocrine Pancreas | 15–20% |
| Immunologic Responses And Autoimmune Disorders | 5–10% |
| Bioenergetics And Metabolism | 5–10% |
| Endocrine Function Of Adipose Tissue | 5–10% |
| Pharmacologic Treatment Of Altered Endocrine Function | 10–15% |
| Topic | % |
|---|---|
| Microscopic and Gross Structure | 10-15% |
| Embryology and Development | 3-5% |
| Blood Supply of the Gut | 3-5% |
| Immunological Responses and Autoimmune Disorders | 5-10% |
| Infectious Diseases and Malignancies | 15-20% |
| Cephalic Phase | 5-10% |
| Neural and Hormonal Control Throughout the GI Tract | 15-20% |
| Gastric and Intestinal Secretion, Digestion and Absorption | 20-25% |
| Integrated Control of Satiety, Thirst, and Appetite | 3-5% |
| Hepatobiliary Functions | 3-5% |
| Nutritional Health | 3-5% |
| Pharmacologic Treatment of GI System Disorders and Dysfunctions | 15-20% |
| Topic | % |
|---|---|
| Microscopic and Gross Structure of the Urinary System | 4–8% |
| Embryology and Development | 2–4% |
| Immunologic Responses and Autoimmune Disorders | 8–12% |
| Infectious Diseases and Malignancies | 4–8% |
| Bladder Function and Regulation | 2–4% |
| Renal Function and Regulation | 25–35% |
| Mechanisms of Acid-Base Regulation | 30–35% |
| Pharmacologic Treatment of the Genitourinary and Renal System Disorders and Dysfunctions | 10–15% |
| Topic | % |
|---|---|
| Female Reproduction | 25–35% |
| Male Reproduction | 5–10% |
| Stages of Growth and Development | 5–10% |
| Genetics | 20–25% |
| Human Sexual Response | 5–10% |
| Pharmacologic and Environmental Influences on Growth and Development | 20–25% |
| Topic | % |
|---|---|
| Microscopic and Gross Structure | 10–15% |
| Embryology and Development | 5–10% |
| Immunologic Responses and Autoimmune Disorders | 10–15% |
| Infectious Diseases | 40–50% |
| Physiological Functions of the Skin | 10–15% |
| Pharmacologic Treatment of Integumentary System Disorders, Dysfunctions, and Infections | 15–20% |
| Topic | % |
|---|---|
| Microscopic and Gross Structure of Skeletal and Smooth Muscle | 25–30% |
| Microscopic and Gross Structure of Bone | 20–25% |
| Microscopic and Gross Structure of Joints | 20–25% |
| Acute and Chronic Injuries, Disorders, and Diseases | 10-20% |
| Pharmacology of the Musculoskeletal System and the Neuromuscular Junction | 10–15% |
| Topic | % |
|---|---|
| Microscopic and Gross Structure | 6–12% |
| Embryology and Development | 4–6% |
| Immunologic Responses and Autoimmune Disorders | 6–12% |
| Infectious Diseases and Malignancies | 11–16% |
| Physiologic Function of Ventilation and Its Control | 36–41% |
| Determinants of Respiratory Patterns and Control | 6–12% |
| Causes of Hypoxemia and Hypercapnia | 6–12% |
| Integrated Control of Respiratory Function | 6–12% |
| Pharmacologic Treatment of Respiratory System Disorders and Dysfunction | 11–16% |
| Topic | % |
|---|---|
| Biomolecules, Cell and Molecular Biology | 20–25% |
| Metabolism and Nutritional Biochemistry | 25–30% |
| Human Genetics | 20–25% |
| Cell Signaling | 10-15% |
| Hematology | 15-20% |
| Topic | % |
|---|---|
| Head and Neck Anatomy | 25–30% |
| Back and Extremity Anatomy | 20–25% |
| Body Cavities Anatomy (Viscera) | 25–30% |
| Histology/Development | 20–25% |
| Topic | % |
|---|---|
| Microanatomy of CNS structures | 5-8% |
| Meninges, Ventricles, CSF | 5-8% |
| CNS Development | 5-8% |
| Neuroplasticity | 5-8% |
| Spinal Cord | 10-15% |
| Brainstem | 12-18% |
| Basal Ganglia | 5-8% |
| Cerebellum | 5-8% |
| Thalamus | 5-8% |
| Hypothalamus | 5-8% |
| Cerebrum | 15-20% |
| Limbic Structures | 5-8% |
| Topic | % |
|---|---|
| Bacteriology | 25-30% |
| Virology | 20-25% |
| Mycology/Parasitology | 20-25% |
| Immunology | 25-30% |
| Topic | % |
|---|---|
| Basic Principles of Pharmacology | 12-20% |
| Chemotherapeutic Agents | 10-15% |
| Foundational Pharmacology of the Nervous System | 15-22% |
| Foundational Cardiovascular, Renal, Pulmonary, Hematologic Pharmacology | 15-22% |
| Foundational Pharmacology of the Endocrine System | 10-15% |
| Foundational Pharmacology of the Gastrointestinal System | 5-8% |
| Foundational Pharmacology of the Immune System | 10-12% |
| Topic | % |
|---|---|
| Cellular Physiology in Health and Disease | 5-10% |
| Systems Physiology in Health and Disease | 60-75% |
| Acid-base Regulation | 5-10% |
| Reflex Control Mechanisms in Health and Disease | 15-20% |
National Board of Osteopathic Medical Examiners, Inc.
Corporate Offices:
8765 W. Higgins Rd Suite 200 ·
Executive Offices:
101 West Elm Street Suite 230 ·
contact us · site map
Copyright © 2023, NBOME. All rights reserved.
Privacy Notice · Terms of Use
The names NBOME and the National Board of Osteopathic Medical Examiners are registered service marks of the National Board of Osteopathic Medical Examiners, Inc. (NBOME). The NBOME seal, the assessment names COMAT®, COMLEX®, COMLEX-USA®, COMSAE®, COMVEX®, WelCOM® and CATALYST™, and all other designated marks and styles are trademarks or service marks of the NBOME. Unauthorized use of any NBOME mark to promote the goods or services of others is prohibited and subject to all rights and remedies under applicable federal and state law.
Website developed by Zero Defect Design LLC.
